Subscribe
shutterstock_1635596416_sundry_photography
Sundry Photography / Shutterstock.com
15 October 2020Big PharmaSarah Morgan

Fed Circuit refuses Amgen unit appeal in win for Sanofi

The US Court of Appeals for the Federal Circuit has dismissed Immunex’s appeal against a decision invalidating its patent on treating inflammatory disorders.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Cozen O'Connor snaps up Kilpatrick Townsend duo
28 October 2020   Cozen O’Connor has hired Jeffrey Gendzwill and Keith Fredlake from Kilpatrick Townsend & Stockton into the firm’s Washington, DC office.
Americas
Kilpatrick Townsend hires litigation team from DLA Piper
19 October 2020   Kilpatrick Townsend & Stockton has strengthened its life sciences expertise with the addition of a patent litigation team, that includes four litigators from DLA Piper.
Big Pharma
Sanofi and GSK launch coronavirus vaccine collaboration
14 April 2020   Sanofi and GlaxoSmithKline are pooling resources to create a vaccine for COVID-19, in what they call an “unprecedented” collaboration between the two pharma companies.


Editor's picks

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

Editor's picks

Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025

More on this story

Americas
Cozen O'Connor snaps up Kilpatrick Townsend duo
28 October 2020   Cozen O’Connor has hired Jeffrey Gendzwill and Keith Fredlake from Kilpatrick Townsend & Stockton into the firm’s Washington, DC office.
Americas
Kilpatrick Townsend hires litigation team from DLA Piper
19 October 2020   Kilpatrick Townsend & Stockton has strengthened its life sciences expertise with the addition of a patent litigation team, that includes four litigators from DLA Piper.
Big Pharma
Sanofi and GSK launch coronavirus vaccine collaboration
14 April 2020   Sanofi and GlaxoSmithKline are pooling resources to create a vaccine for COVID-19, in what they call an “unprecedented” collaboration between the two pharma companies.

More on this story

Americas
Cozen O'Connor snaps up Kilpatrick Townsend duo
28 October 2020   Cozen O’Connor has hired Jeffrey Gendzwill and Keith Fredlake from Kilpatrick Townsend & Stockton into the firm’s Washington, DC office.
Americas
Kilpatrick Townsend hires litigation team from DLA Piper
19 October 2020   Kilpatrick Townsend & Stockton has strengthened its life sciences expertise with the addition of a patent litigation team, that includes four litigators from DLA Piper.
Big Pharma
Sanofi and GSK launch coronavirus vaccine collaboration
14 April 2020   Sanofi and GlaxoSmithKline are pooling resources to create a vaccine for COVID-19, in what they call an “unprecedented” collaboration between the two pharma companies.

More features

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims